Section 5A RTA 1988: The Drug-Driving Offence
The drug-driving offence under Section 5A of the Road Traffic Act 1988 was introduced by the Crime and Courts Act 2013 and came into force on 2 March 2015. It is a strict liability offence — the prosecution does not need to prove impairment. It is sufficient to prove that the defendant drove or attempted to drive a motor vehicle on a road or public place with a specified controlled drug in their blood above the prescribed limit.
The prescribed limits are set out in the Drug Driving (Specified Limits) (England and Wales) Regulations 2014 (SI 2014/2868). There are two categories of drug: zero-tolerance drugs, where the limit is set just above the limit of analytical detection, and prescribed medication drugs, where the limit is set at a level that should not be exceeded by a patient taking medication as prescribed.
On conviction, the mandatory penalty is a minimum twelve-month driving disqualification, an unlimited fine, and up to six months' imprisonment. A second conviction within ten years carries a minimum three-year ban. The offence is recorded on the defendant's DVLA licence and may affect employment in roles requiring a driving licence or professional registration.
The strict liability nature of the offence means that the central battleground in most drug-driving cases is the reliability of the blood analysis. A forensic toxicology expert witness can challenge the prosecution's evidence on multiple grounds, support a statutory prescribed medication defence, or perform a back-calculation to estimate the concentration at the time of driving.
Prescribed Limits Under the 2014 Regulations
The following limits apply in England and Wales. Scotland operates under separate regulations with identical limits for most substances. The half-life data is relevant to back-calculation analysis.
Zero-Tolerance Drugs (Illegal Drugs)
| Drug | Blood Limit | Approximate Half-Life |
|---|---|---|
| Cannabis (THC) | 2 µg/L | 1–4 days (chronic users: up to 30 days) |
| Cocaine (benzoylecgonine) | 50 µg/L | 5–8 hours |
| MDMA (ecstasy) | 10 µg/L | 6–10 hours |
| Heroin (6-MAM) | 5 µg/L | 20–90 minutes |
| Ketamine | 20 µg/L | 2–4 hours |
| LSD | 1 µg/L | 3–5 hours |
| Methylamphetamine | 10 µg/L | 10–12 hours |
| 6-Monoacetylmorphine (6-MAM) | 5 µg/L | 20–90 minutes |
Prescribed Medication Drugs
| Drug | Blood Limit | Typical Therapeutic Range |
|---|---|---|
| Diazepam | 550 µg/L | 200–2,500 µg/L |
| Clonazepam | 50 µg/L | 20–70 µg/L |
| Morphine | 80 µg/L | 10–100 µg/L |
| Methadone | 500 µg/L | 100–400 µg/L |
| Amphetamine | 250 µg/L | 20–200 µg/L |
| Flunitrazepam | 300 µg/L | 5–15 µg/L |
| Lorazepam | 100 µg/L | 10–30 µg/L |
| Oxazepam | 300 µg/L | 200–1,400 µg/L |
Source: Drug Driving (Specified Limits) (England and Wales) Regulations 2014, SI 2014/2868. Therapeutic ranges are indicative and subject to individual pharmacokinetic variation.
The Prescribed Medication Statutory Defence (Section 5A(3))
Section 5A(3) of the RTA 1988 provides a statutory defence where the drug was taken in accordance with a prescription, the defendant took it as directed by the prescriber or as indicated in the accompanying instructions, and the defendant's driving was not impaired by the drug. All three elements must be established on the balance of probabilities.
The defence is available only for the prescribed medication drugs listed in the 2014 Regulations — not for zero-tolerance drugs. A defendant who tests positive for diazepam above the 550 µg/L limit may advance the defence; a defendant who tests positive for cannabis above 2 µg/L may not.
A forensic toxicologist is essential to this defence. The expert will review the prescription records, the blood analysis results, and the pharmacokinetic profile of the drug to assess whether the blood concentration is consistent with therapeutic use as prescribed. Where the concentration is significantly above the therapeutic range, the expert will explain whether this is consistent with accumulation, polypharmacy, or non-prescribed use.
Key case: DPP v Agyemang [2017] EWHC 3064 (Admin)
The Divisional Court confirmed that the statutory defence requires the defendant to establish all three elements. A prescription alone is insufficient — the defendant must also show they followed the prescriber's instructions and that their driving was not impaired. Expert evidence on the pharmacokinetic profile of the drug is typically required to address the first two elements.
The impairment element is particularly important where the blood concentration is significantly above the therapeutic range. The toxicologist will consider whether the concentration is consistent with acute intoxication or chronic tolerance, and whether the defendant's driving behaviour — as recorded in the police evidence — is consistent with impairment at the measured concentration.
Challenging the Blood Analysis: Five Grounds
Even where no statutory defence is available, a forensic toxicologist can challenge the reliability of the prosecution's blood analysis. The five principal grounds are set out below.
1. Chain of custody
The blood sample must be properly labelled, stored, and transported from the point of collection to the laboratory. Any break in the chain of custody creates a risk of contamination, mislabelling, or sample mix-up. The toxicologist will review the exhibit documentation — including the MG/DD/A and MG/DD/B forms — to identify any irregularities that undermine the integrity of the sample.
2. Sample integrity and storage conditions
Blood samples degrade over time, particularly if not stored at the correct temperature (typically 4°C). Enzymatic conversion of endogenous ethanol, bacterial contamination, and haemolysis can all affect drug concentrations. The toxicologist will assess whether the storage conditions recorded in the documentation are consistent with the analytical results and whether any degradation could have affected the measured concentration.
3. Analytical methodology
The prosecution laboratory must use validated analytical methods. Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are the accepted standards for confirmatory analysis. The toxicologist will review the laboratory's method validation data, the specific analytical run records, and the chromatograms to identify any deviations from validated procedures or quality control failures.
4. Measurement uncertainty
Every analytical measurement carries an inherent degree of uncertainty. Under ISO 17025 accreditation, laboratories must calculate and report expanded measurement uncertainty. Where the measured concentration is close to the prescribed limit, the expanded uncertainty (typically expressed at a 95% confidence level) may place the true concentration below the threshold. The toxicologist will calculate the expanded measurement uncertainty and assess whether it raises a reasonable doubt about whether the prescribed limit was exceeded.
5. Back-calculation to time of driving
Where there is a significant delay between the alleged offence and the blood sample being taken, the drug concentration at the time of driving may have been materially different from the measured concentration. The toxicologist can perform a back-calculation using the drug's known elimination half-life to estimate the concentration at the time of driving. The result is expressed as a range to account for inter-individual variability in elimination rates.
Back-Calculation and Measurement Uncertainty in Practice
Back-calculation and measurement uncertainty are the two most technically demanding aspects of drug-driving expert evidence. Both require an ISO 17025 accredited forensic toxicologist with specific expertise in pharmacokinetics and analytical chemistry.
Back-Calculation
Where there is a significant delay between the alleged offence and the blood sample being taken — for example, where the defendant was not arrested at the roadside but attended a police station some hours later — the drug concentration at the time of driving may have been materially different from the measured concentration.
The toxicologist performs a back-calculation using the drug's known elimination half-life and the elapsed time between the alleged offence and the blood sample. For most drugs, elimination follows first-order kinetics — the concentration decreases by a fixed percentage per unit time. However, elimination rates vary significantly between individuals depending on genetic factors, liver function, concurrent medication, and chronic use.
The result of a back-calculation is therefore expressed as a range, not a single figure. Where the lower end of the range falls below the prescribed limit, the expert can give evidence that the concentration at the time of driving may not have exceeded the threshold.
Measurement Uncertainty
Every analytical measurement carries an inherent degree of uncertainty arising from calibration, sample preparation, instrument precision, and analyst variability. Under ISO 17025 accreditation, prosecution laboratories are required to calculate and report expanded measurement uncertainty for all quantitative drug analyses.
The prosecution's reported concentration is a point estimate. The expanded measurement uncertainty — typically expressed at a 95% confidence level — defines the range within which the true concentration is likely to fall. Where the measured concentration is close to the prescribed limit, the lower bound of the expanded uncertainty interval may fall below the threshold.
In R v Brock [2018] EWCA Crim 2704, the Court of Appeal considered the relevance of measurement uncertainty in drug-driving cases. The court confirmed that measurement uncertainty is a legitimate subject for expert evidence and that, where it is sufficient to raise a reasonable doubt, the jury should be directed accordingly.
How to Instruct a Forensic Toxicologist: A Step-by-Step Guide
A well-prepared letter of instruction is essential to obtaining a focused, CrimPR Rule 19 compliant expert report. The following five steps reflect best practice for drug-driving instructions.
Obtain the prosecution's blood analysis evidence
Request the blood analysis certificate, the full laboratory report, and the MG/DD/A and MG/DD/B forms under disclosure. These documents are essential for the toxicologist's review and should be obtained before instruction. If the prosecution has not provided the raw analytical data — chromatograms and calibration records — request these under the Criminal Procedure and Investigations Act 1996 disclosure regime.
Identify the defence theory
Determine whether the defence will challenge the reliability of the blood analysis, advance a statutory prescribed medication defence under Section 5A(3), or both. The letter of instruction should set out the specific questions the expert is asked to address. Avoid open-ended instructions — a focused letter produces a focused report.
Confirm LAA funding and prior authority
Check whether the expert's fee exceeds the LAA prescribed rate for forensic toxicology in criminal proceedings. If so, obtain prior authority from the LAA before the instruction is made. Expert Witness UK can provide a fee estimate and CV for prior authority applications. See our guide to Prior Authority LAA applications for further detail.
Send a CrimPR Rule 19 compliant letter of instruction
The letter of instruction must set out the facts of the case, the specific questions the expert is asked to address, the relevant legal framework, and the court timetable. The expert must be told that their overriding duty is to the court under CrimPR Rule 19.2(1). Include all relevant documents as exhibits.
Review the report for CrimPR Rule 19.4 compliance
Before serving the report, check that it contains all mandatory elements: qualifications, instructions summary, facts and assumptions, opinion, range of opinion where applicable, conclusions, and the Rule 19 written declaration. Expert Witness UK reviews all reports for compliance before delivery.
LAA Funding for Drug-Driving Toxicology Expert Evidence
Forensic toxicology expert witnesses in drug-driving cases are covered by the Legal Aid Agency's Criminal Legal Aid scheme. Expert fees are subject to the LAA's prescribed rates for expert witnesses in criminal proceedings, which are set out in the Criminal Legal Aid (Remuneration) Regulations 2013 (as amended).
Where the expert's fee exceeds the prescribed rate, prior authority from the LAA is required before the instruction is made. A prior authority application must include a justification for the higher rate, the expert's CV, and a fee estimate. Expert Witness UK can provide all of these documents and has experience in supporting prior authority applications for forensic toxicology instructions.
The LAA's prior authority process is described in detail in our Prior Authority LAA Guide. The relevant prescribed rates for forensic toxicology are set out in our Expert Witness Fees & LAA Rates page.
Expert Witness UK accepts LAA rates
All Expert Witness UK panel toxicologists accept LAA prescribed rates for drug-driving instructions. We provide fee estimates, CVs, and supporting documentation for prior authority applications at no additional charge.
Frequently Asked Questions
Common questions from criminal defence solicitors instructing forensic toxicologists in drug-driving cases.
Related Guides and Service Pages
Further resources for criminal defence solicitors and barristers instructing expert witnesses in drug-related proceedings.
Toxicology Expert Witnesses
Full overview of our forensic toxicology panel — post-mortem toxicology, hair strand testing, and drug-driving analysis.
Drug & Alcohol Expert Witnesses
Addiction medicine and dependency assessment experts for family court and criminal proceedings.
Drug & Alcohol Testing Methods Explained
A technical guide to hair strand, urine, blood, and oral fluid testing — methodology, detection windows, and limitations.
Criminal Defence Expert Witnesses
Our full panel of expert witnesses for criminal defence proceedings — psychology, psychiatry, forensic, and toxicology.
CrimPR Rule 19 Compliance Guide
The expert witness's overriding duty to the court, report requirements, and written declarations under Part 19.
Prior Authority LAA Guide
How to obtain prior authority from the LAA for expert witness fees that exceed the prescribed rate.